FABHALTA Risk Evaluation and Mitigation Strategy Owner’s Manual
FABHALTA Risk Evaluation and Mitigation Strategy Product Specifications Risk: serious infections caused by encapsulated bacteria Application Number: NDA 218276 Application Holder: Novartis Pharmaceuticals Corporation Initial REMS Approval: 12/2023 Most Recent REMS Update: 05/2024 Product Usage Instructions For Healthcare Providers: Review…